Skip to main content
. Author manuscript; available in PMC: 2010 Feb 15.
Published in final edited form as: Virology. 2007 Nov 26;372(1):107. doi: 10.1016/j.virol.2007.10.016

Figure 2. REP 9 targets the GP of LCMV.

Figure 2

(A) Blocking of VSVΔG*-LCMVGP infection by inactivated LCMV cl-13: VeroE6 cells were blocked with inactivated LCMV cl-13 (LCMVi) or VSV (VSVi) at the indicated ratios of virus particles per cell followed by infection with 200 PFU of the indicated viruses. Infection of LCMV was assessed by immunofluorescence staining for LCMVNP and VSVΔG*-LCMVGP and VSV-GFP were detected using the GFP reporter. Infected cells per well were scored (n = 3, ± SD). (B) Inhibition of infection of VSVΔG*-LCMVGP with REP 9: LCMV, VSVΔG*-LCMVGP, and VSV-GFP (500 PFU) were pre-incubated with increasing concentrations of REP 9 and added to monolayers of VeroE6 cells. Infection was determined as in (A). Data are positive cells per well, n = 3, ± SD.